Late Cardiac Involvement of the Glycogen Storage Disease Type IIIa with Massive Left Ventricular Hypertrophy and Late Gadolinium Enhancement.
作者信息
Çimen Bedirhan Bozkurt, Yilmaz Samet
机构信息
Cardiology Department, Pamukkale University, Pamukkale, Denizli, Turkey.
出版信息
Acta Cardiol Sin. 2024 Sep;40(5):648-650. doi: 10.6515/ACS.202409_40(5).20240528B.
Abstract
摘要
相似文献
1
Late Cardiac Involvement of the Glycogen Storage Disease Type IIIa with Massive Left Ventricular Hypertrophy and Late Gadolinium Enhancement.Ⅲa型糖原贮积病的晚期心脏受累伴左心室显著肥厚及延迟钆增强
Acta Cardiol Sin. 2024 Sep;40(5):648-650. doi: 10.6515/ACS.202409_40(5).20240528B.
2
Glycogen storage disease with massive left ventricular hypertrophy and increased native T1: a case report.糖原贮积病伴左心室肥厚及固有T1值升高：一例报告
Eur Heart J Case Rep. 2023 Sep 11;7(9):ytad458. doi: 10.1093/ehjcr/ytad458. eCollection 2023 Sep.
3
Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.晚发型庞贝病患者心脏受累的模式及预后价值：一种全面的心血管磁共振方法
J Cardiovasc Magn Reson. 2016 Dec 7;18(1):91. doi: 10.1186/s12968-016-0311-9.
4
Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.心脏磁共振左心室肥厚和晚期钆增强与法布瑞病的不良心脏事件相关。
Radiology. 2020 Jan;294(1):42-49. doi: 10.1148/radiol.2019191385. Epub 2019 Oct 29.
5
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.酶替代治疗 1 年后法布病患者心肌储存、炎症和心脏表型。
Circ Cardiovasc Imaging. 2019 Dec;12(12):e009430. doi: 10.1161/CIRCIMAGING.119.009430. Epub 2019 Dec 12.
6
Late-gadolinium enhancement in a subject with normal left ventricular function.左心室功能正常受试者的延迟钆增强。
Radiol Case Rep. 2020 Sep 25;15(11):2464-2470. doi: 10.1016/j.radcr.2020.09.015. eCollection 2020 Nov.
7
[Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].[致心律失常性心肌病。利用心脏磁共振成像观察心室受累模式]
Rev Esp Cardiol. 2011 Dec;64(12):1114-22. doi: 10.1016/j.recesp.2011.07.014. Epub 2011 Oct 24.
8
Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa.糖原贮积病 IIIa 型 11 例患儿的基因分析及长期治疗监测
J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):923-930. doi: 10.1515/jpem-2019-0453.
9
Glycogen storage diseases presenting as hypertrophic cardiomyopathy.表现为肥厚型心肌病的糖原贮积病。
N Engl J Med. 2005 Jan 27;352(4):362-72. doi: 10.1056/NEJMoa033349.
10
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.一项关于成年III型糖原贮积病患者的回顾性纵向研究及综合综述。
Mol Genet Metab Rep. 2021 Nov 11;29:100821. doi: 10.1016/j.ymgmr.2021.100821. eCollection 2021 Dec.
本文引用的文献
1
Glycogen storage disease with massive left ventricular hypertrophy and increased native T1: a case report.糖原贮积病伴左心室肥厚及固有T1值升高：一例报告
Eur Heart J Case Rep. 2023 Sep 11;7(9):ytad458. doi: 10.1093/ehjcr/ytad458. eCollection 2023 Sep.
2
Narrative review of glycogen storage disorder type III with a focus on neuromuscular, cardiac and therapeutic aspects.糖原贮积病III型的叙述性综述：聚焦神经肌肉、心脏及治疗方面
J Inherit Metab Dis. 2021 May;44(3):521-533. doi: 10.1002/jimd.12355. Epub 2021 Jan 3.
3
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.欧洲心脏病学会 EURObservational Research Programme 的心肌病注册研究：心肌病成年患者的基线数据和当代管理。
Eur Heart J. 2018 May 21;39(20):1784-1793. doi: 10.1093/eurheartj/ehx819.
4
Infiltrative Cardiomyopathies.浸润性心肌病
Clin Med Insights Cardiol. 2015 Jul 8;9(Suppl 2):29-38. doi: 10.4137/CMC.S19706. eCollection 2015.
5
Glycogen storage disease type III diagnosis and management guidelines.糖原贮积病 III 型的诊断和管理指南。
Genet Med. 2010 Jul;12(7):446-63. doi: 10.1097/GIM.0b013e3181e655b6.
Zotero 插件